Seres Therapeutics Inc — Quarterly Financial Statistics (NASDAQ:MCRB) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics

Quarterly Annual

Cash from operating activities 34.68 M38.88 M26.91 M-13.29 M2.21 M-14.71 M 1.12 M Cash from investing activities 141.14 M-90 K34 K181 K8 000-181 K 42 K Cash from financing activities 73.35 M-1.74 M1.18 M061 K12.66 M 13.9 M Free cash flow 34.55 M38.79 M26.88 M-13.47 M2.2 M-14.74 M 865 K

Haberler

Seres Therapeutics, Inc. (MCRB) Discusses Leadership Transition, Strategic Direction and Microbiome Therapeutics Platform Prepared Remarks Transcript

Seres hisseleri, Faz 2 çalışmasını durdurması ve işgücünü %30 azaltması sonrası düştü

Seres stock falls after pausing Phase 2 study and cutting workforce by 30%

Seres Therapeutics: Strong SER-155 Data, But Dilution Risk Now Warrants A 'Hold'

Seres Therapeutics publishes new insights on VOWST mechanism

3 Beaten-Down Biotech Stocks to Buy for a 2026 Turnaround

Oaktree Acquisition Corp. III Life Sciences, David A. Berry’yi yönetim kuruluna atadı

Oaktree Acquisition Corp. III Life Sciences appoints David A. Berry as director

Seres, SER-155 kan dolaşımı enfeksiyonu çalışmasına ilişkin yeni veriler sunacak

Seres to present new data on SER-155 bloodstream infection study

Seres Therapeutics nakit akışını uzatmak için işgücünde kesintiye gidiyor

Seres Therapeutics announces workforce reduction to extend cash runway